Acute kidney injury in patients treated for symptomatic peripheral arterial disease

Contrast-induced nephropathy in patients undergoing percutaneous transluminal angioplasty in symptomatic peripheral artery disease – A prospective cohort study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26709

Enrollment

350

Registered

2014-12-16

Start date

2013-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PAD: Peripheral artery disease CRI: Chronic renal insufficiency IC: Intermittent claudication CLI: Critical limb ischemia GFR: Glomerular filtration rate PTA: Percutaneous transluminal angioplasty CIN: Contrast induced nephropathy PCI: Percutaneous coronary intervention CKD: Chronic kidney disease

Interventions

Endovascular procedures for symptomatic peripheral artery disease

Eligibility

Inclusion criteria

Inclusion criteria: All patients presenting at the department of vascular surgery between May 1st 2013 and February 15th 2014

Exclusion criteria

Exclusion criteria: Exclusion criteria were end-stage renal disease (ESRD), no renal function test, any CT-angiography or percutaneous coronary intervention in the first year of follow-up

Design outcomes

Primary

Measure	Time frame
Acute kidney injury (contrast-induced nephropathy) CIN was determined as a >25% increase of baseline creatinine level day 5 post-procedural	—

Secondary

Measure	Time frame
Renal decline 1 year after endovascular interventions	—

Contacts

Public ContactT.A. Sigterman

Heelkunde, Atrium Medisch Centrum Postbus 4446

timsigterman@gmail.com0031455766599 of 0031622424470, sein *7668

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)